SCHEMBL17308602

SCHEMBL17308602

Cc1ccc(NC2CCOCC2)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HTT P42858 2/20 0.46
NPC1 O15118 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EPHX2 P34913 1/20 0.46
PDE2A O00408 1/20 0.45
PDE10A Q9Y233 1/20 0.45
POLB P06746 3/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ICMT O60725 1/20 0.43
FKBP1A P62942 1/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 2/20 0.41
USP2 O75604 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26448675 0.85 HTT (0.60) RAPGEF4HTTNPC1TSHRRAB9A
SCHEMBL171233 0.81 BACE1 (0.46) RAPGEF4HTTNPC1RAB9ASMN1; SMN2
SCHEMBL17072651 0.80 PDE2A (0.40) EPHX2PDE2APDE10APOLBMAPK1
SCHEMBL17070966 0.80 NR1H4 (0.44) PDE2APDE10APOLBMAPK1
SCHEMBL15830060 0.77 BACE1 (0.48) RAPGEF4TSHRSMN1; SMN2PDE2APDE10A
SCHEMBL13634634 0.76 PRMT5 (0.48) TSHRPOLBMAPK1
SCHEMBL178453 0.75 MAPK1 (0.53) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL15830050 0.75 BACE1 (0.44) HTTNPC1RAB9ASMN1; SMN2POLB
SCHEMBL15830062 0.75 GAK (0.47) HTTSMN1; SMN2PDE10AALDH1A1MAPK1
SCHEMBL26279360 0.75 UBE2M (0.61) HTTNPC1TSHRRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344434-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 RAPGEF4 2414/4885TDP1 815/4885HTT 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.